Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Total Non-Current Liabilities: 2013-2018

Historic Total Non-Current Liabilities for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2018 value amounting to $7.1 million.

  • Soleno Therapeutics' Total Non-Current Liabilities fell 29.06% to $7.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $7.8 million, marking a year-over-year decrease of 29.06%. This contributed to the annual value of $7.1 million for FY2018, which is 0.48% down from last year.
  • As of FY2018, Soleno Therapeutics' Total Non-Current Liabilities stood at $7.1 million, which was down 0.48% from $7.1 million recorded in FY2017.
  • Soleno Therapeutics' 5-year Total Non-Current Liabilities high stood at $18.3 million for FY2014, and its period low was $2.1 million during FY2016.
  • In the last 3 years, Soleno Therapeutics' Total Non-Current Liabilities had a median value of $7.1 million in 2018 and averaged $5.4 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first tumbled by 73.39% in 2015, then spiked by 244.45% in 2017.
  • Soleno Therapeutics' Total Non-Current Liabilities (Yearly) stood at $18.3 million in 2014, then slumped by 73.39% to $4.9 million in 2015, then slumped by 57.52% to $2.1 million in 2016, then skyrocketed by 244.45% to $7.1 million in 2017, then declined by 0.48% to $7.1 million in 2018.